Skip to content

Enteral Feeding Composition and Acute Respiratory Failure

Effect of Enteral Feeding's Macronutrient Composition on Inflammatory Mediators, Oxidative Stress and Outcomes in Intensive Care Unit Patients With Acute Respiratory Failure

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02421614
Enrollment
48
Registered
2015-04-20
Start date
2013-08-31
Completion date
2015-12-31
Last updated
2016-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Failure

Keywords

acute respiratory failure, lung, enteral feeding, feeding composition, olive, high fat

Brief summary

This study aimed to investigate the effect of enteral feeding's macronutrient composition on inflammatory mediators, oxidative stress and outcomes in Intensive Care Unit (ICU) patients with acute respiratory failure. In this double-blind randomized control trial, 42 patients of both sexes and diagnosed with acute respiratory failure in ICU that receive enteral feeding, will be randomly assigned to three groups of 14 each. First Intervention group; high-protein low-carbohydrate diet with high olive oil, the second intervention group; high-protein low-carbohydrate diet with high sunflower oil and control; high-protein kitchen formula. Intravenous levels of uric acid, high sensitive C-Reactive Protein (hs-CRP), Interleukin 6 (IL-6) and Total Antioxidant Capacity (TAC) measured at days 0 and 10. As well as, organ failure, duration of ventilation, length of ICU stay and mortality rates will be evaluated.

Interventions

OTHERhigh-protein low-carbohydrate diet with high olive oil
OTHERhigh-protein low-carbohydrate diet with high sunflower oil

Sponsors

Zahra Vahdat Shariatpanahi
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* enrolled in ICU * age older than 18 years old * need to be mechanically ventilation * have enteral feeding * no previous diabetes * no previous HIV infection * no previous nervous system * no previous liver failure * no previous nephrotic syndrome * not passed more than 48 hours from diagnose of acute respiratory failure

Exclusion criteria

* death at less than three days of enteral feeding administration * extubation at less than three days of enteral feeding administration

Design outcomes

Primary

MeasureTime frameDescription
length of ventilationThe number of days at least 3, to which days that patient extubatedThe number of days from the patient intubation to his/her extubation

Secondary

MeasureTime frame
Levels of high sensitive C-Reactive Protein (hs-CRP) in patient's vein blood10 days
Levels of Total Antioxidant Capacity (TAC) in patient's vein blood10 days
Levels of uric acid in patient's vein blood10 days
Levels of Interleukin 6 (IL-6) in patient's vein blood10 days

Countries

Iran

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026